Risk factors and outcomes in non-transplant patients with extended-spectrum beta-lactamase-producing <i>Escherichia coli</i> bacteremia: a retrospective study from 2013 to 2016.

Antimicrob Resist Infect Control · 2019 · PMC6712786 · PMID 31467670

Europe PMC DOI

hedged sentences

0.0580

closest p · 1.2× alpha

0.0580

boldest claim

The sentences

marginally significantP = 0.058so close (0.05 < p ≤ 0.1)

Based on our multivariate analysis, appropriate empirical antibiotic treatment also appeared to be a protective factor that can reduce the mortality rate, although this effect was marginally significant (OR = 2.526, P = 0.058).

also in 26,082 other papers

an increasing trendno p-value reported

Available monitoring data showed that the resistance rate of Enterobacteriaceae to β-lactam antibiotics such as cefotaxime, ceftazidime, cefepime, and piperacillin-tazobactam decreased from 2005 to 2014, while the meropenem (2005, 2.8%; 2014, 4.5%) and ertapenem (2005, 5.5%; 2014, 8.9%) resistance rates showed an increasing trend [ 11 ].

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.